Results 51 to 60 of about 3,588 (132)
Background Androgenetic alopecia (AGA) is the most common type of hair loss in men. Finasteride and dutasteride are oral 5-alpha-reductase inhibitors. This study compared their efficacy and safety in Iranian men with moderate to severe AGA.Methods This ...
Nazila Poostiyan +4 more
doaj +1 more source
Process Factors Affecting the Preparation and Characterization of Dutasteride Nanosuspension
Dutasteride, a synthetic compound belonging to the 4-azasteroid class, functions as a selective and competitive inhibitor of both type 1 and type 2 5-alpha-reductase enzymes.
Shaimaa N. Abd-Alhammid +1 more
doaj +1 more source
ABSTRACT Background Androgenetic alopecia (AGA) is the most prevalent type of hair loss, exerting a significant negative impact on patients' quality of life. The limited efficacy, potential adverse effects, and poor patient adherence of single‐agent therapies highlight substantial unmet needs in clinical management.
Zhuhao Lai, Yi Zhou, Rui Zhou
wiley +1 more source
Purpose: Finasteride and dutasteride are used to treat benign prostatic hyperplasia (BPH) and reduce the risk of developing prostate cancer. Finasteride blocks only the type 2 form of 5-alpha-reductase, whereas dutasteride blocks both type 1 and 2 forms
Dae Yul Yang +10 more
doaj +1 more source
ABSTRACT Background Androgenetic alopecia (AGA) is a common chronic condition significantly impacting quality of life (QoL), but few studies have explored treatment outcomes in real‐world digital health settings. Aims The objective of this study is to evaluate the effects of AGA treatment delivered through a digital healthcare platform on patient ...
Angela C. Bersch‐Ferreira +7 more
wiley +1 more source
Treatment of male androgenetic alopecia with 5α-reductase inhibitors is efficacious. However, the risk of adverse sexual effects remains controversial.
Solam Lee +3 more
doaj +1 more source
Objective: To compare the PSA and TGF-β1 plasma level before and after administration of a 5α-reductase inhibitor (dutasteride) and an anti estrogen (tamoxifen) in nonobstructive patients with BPH.
Rachmat Budi Prasetyo +2 more
doaj +1 more source
Min-Soo KimDepartment of Pharmaceutical Engineering, Inje University, Gimhae, Gyeongnam, Republic of KoreaAbstract: The objectives of this study were to develop a novel solid dutasteride formulation with improved physicochemical properties and oral ...
Kim MS
doaj
Objective: To evaluate the success rates of tamsulosin and dutasteride as medical therapy based on international prostate symptom score (IPSS) in symptomatic benign prostatic hyperplasia (BPH) patients. Materials & Methods: We reviewed medical records of
Zuhirman Zamzami
doaj +1 more source
Objectives: to find the efficacy dutasteride and green tea in reducing hemorrhage on TURP patients and to evaluate the anti- angiogenesis effect. Methods: Double Blind Randomized Controlled Trial Post Test Only, with 80 samples, randomized into 4 ...
Eriawan Agung Nugroho +3 more
doaj +1 more source

